Overcome the Impairment of NK Cells for Icon and Antibody Immunotherapy of Cancer

HTML  XML Download Download as PDF (Size: 192KB)  PP. 1-8  
DOI: 10.4236/jibtva.2013.21001    4,641 Downloads   9,972 Views  Citations
Author(s)

ABSTRACT

Natural killer (NK) cells play an important role in innate immunity and in mediating antibody and Icon (an antibody-like factor VII/IgG1 Fc immunoconjugate, which, to our best knowledge, was the first therapeutic agent for dual targeting of both the tumor cells and tumor angiogenic endothelial cells) for cancer immunotherapy. However, a common yet often neglected observation and challenge in antibody immunotherapy is that NK cells are often impaired in cancer patients. Here we hypothesize that the impairment of NK cells significantly contributes to host resistance to antibody immunotherapy for cancer. In order for antibody and Icon to achieve their optimal therapeutic efficacy, we briefly reviewed the current strategies to enhance NK activity, including infusion of cytokines, vaccines or NK cells, and the use of dietary supplements. Moreover, from our point of view we identified some remaining challenges and propose to combine these NK-enhancing strategies with Icon or antibody to overcome NK impairment and ultimately to optimize the efficacy of Icon and antibody immunotherapy for cancer.

Share and Cite:

Z. Hu, "Overcome the Impairment of NK Cells for Icon and Antibody Immunotherapy of Cancer," Journal of Immune Based Therapies, Vaccines and Antimicrobials, Vol. 2 No. 1, 2013, pp. 1-8. doi: 10.4236/jibtva.2013.21001.
Journals Menu
Follow SCIRP
Contact us
+1 323-425-8868
customer@scirp.org
WhatsApp +86 18163351462(WhatsApp)
Click here to send a message to me 1655362766
Paper Publishing WeChat

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.